Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered question first ministerially corrected answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1146145

registered interest
date	25/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Per Capita Costs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what allocation per capita was made by his Department in respect of clinical commissioning group (CCG) services in (a) each CCG in York and North Yorkshire, (b) each region of England and (c) England in each year since 2015 (i) in cash terms and (ii) at constant prices.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	290952
answer	answer is ministerial correction date of answer 04/10/2019 answer text <p>In respect of clinical commissioning group (CCG) services, per capita Yorkshire and the Humber CCGs’ allocations for 2015/16 onwards are shown in the attached table. CCG allocation announcements for 2015 onwards, including the breakdown by region of England and total for England in real terms can be found at the following link:</p><p><a href="https://www.england.nhs.uk/allocations/" target="_blank">https://www.england.nhs.uk/allocations/</a></p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 04/10/2019 12:41:19 question first ministerially corrected 07/10/2019 20:32:20 answering member 4362 label Biography information for Edward Argar attachment 1 file name 20190930 PQ290952 - Yorkshire and the Humber per Capita Allocations Table - V2.xlsx title PQ290952 table previous answer version 137321 answering member constituency Charnwood answering member printed Edward Argar answering member 4362 label Biography information for Edward Argar
tabling member	4471 label Biography information for Rachael Maskell

1146151

registered interest
date	25/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the average waiting time was for cancer test results (a) at York Hospital and (b) in England in 2014-15 and each subsequent year.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	290955
answer	answer is ministerial correction date of answer 07/10/2019 answer text <p>Information on the average time taken to receive cancer test results is not collected centrally.</p><p>NHS England publishes monthly performance data against the waiting times standards for diagnostic tests (not exclusive to cancer) and waiting times data of people referred by their general practitioner (GP) with suspected cancer and those subsequently diagnosed and treated for cancer.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 07/10/2019 13:48:08 answering member 4380 label Biography information for Jo Churchill
tabling member	4471 label Biography information for Rachael Maskell

1146292

registered interest
date	25/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Heart Diseases: Surgery
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government how many heart operations they estimate will be cancelled by the NHS in the event of a no-deal Brexit due to a lack of availability of bio-aortic root replacement imports from Italy.
tabling member printed	Lord Bassam of Brighton
uin	HL17787
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products once we have left the EU. This includes the supply of bio-aortic root replacement devices.</p><p>The Department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL17788 question first answered 08/10/2019 15:43:55 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	3504 label Biography information for Lord Bassam of Brighton

1146293

registered interest
date	25/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Heart Diseases: Surgery
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what alternative bio-aortic root replacement supply lines have been developed in the event of a no-deal Brexit interrupting imports from Italy.
tabling member printed	Lord Bassam of Brighton
uin	HL17788
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products once we have left the EU. This includes the supply of bio-aortic root replacement devices.</p><p>The Department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL17787 question first answered 08/10/2019 15:43:55 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	3504 label Biography information for Lord Bassam of Brighton

1146294

registered interest
date	25/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what plans they have to guarantee a continuous supply of insulin for those with type 1 diabetes in the event of a no-deal Brexit.
tabling member printed	Lord Bassam of Brighton
uin	HL17789
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, including insulin, once we have left the EU.</p><p>The Department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages.</p><p>As an example of the preparations being taken by industry to prepare for EU exit, all three suppliers of insulin have publicly stated that they have significantly increased their United Kingdom stockpiles, and have met the Government’s request that they hold at least six weeks’ worth of extra stock in addition to their usual operational stocks.</p> answering member printed Baroness Blackwood of North Oxford question first answered 08/10/2019 15:45:14 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	3504 label Biography information for Lord Bassam of Brighton